26 September 2022
IQ-AI Limited
("IQ-AI" or the "Company")
Issue of Warrants to Employees
IQAI Limited (the "Company" or "IQAI"), the parent company of Wisconsin-based Imaging Biometrics, LLC (IB), which is focused on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively, announces today that it has issued warrants to select employees.
The Board has granted these employees a total of 775,000 warrants to subscribe for one ordinary share each in the Company. The warrants will be exercisable at a price of 2.253 pence per share and are exercisable for 10 years from the date of grant.
The Directors of the Company accept responsibility for the contents of this announcement.
-ENDS-
For further information, please contact:
| IQ-AI Limited Trevor Brown/Brett Skelly/Vinod Kaushal Tel: 020 7469 0930 |
|
Peterhouse Capital Limited (Financial Adviser and Broker) Lucy Williams/Heena Karani Tel: 020 7220 9797 |
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
